The National Medical Commission has quietly pulled the plug on a significant piece of regulatory machinery, withdrawing the Maintenance of Standards of Medical Education Regulations, 2023, with immediate effect. For anyone outside the world of medical education, this may sound like a bureaucratic footnote, but for the thousands of medical colleges, faculty members, and students across the country, it is a change with real consequences. The 2023 regulations had been designed as a blunt, transparent enforcement tool—a detailed rulebook that told institutions exactly what would happen if they failed to maintain the standards expected of them. Under that framework, the NMC could impose fines of up to one crore rupees for each violation, restrict admissions, reduce approved seats, or even withdraw accreditation for as long as five academic years. Colleges that tried to expand their courses or add new programs could find their applications frozen. In the most serious cases, the regulator could recommend that a college lose its permission to operate altogether. The withdrawal of these regulations removes that entire menu of fixed penalties, at least as a single, unified code. But it would be a mistake to read this as a free pass for errant institutions. The requirement to submit Annual Disclosure Reports, the authority of the NMC under the National Medical Commission Act, 2019, and a host of other legal obligations remain very much alive. The change is better understood as a recalibration—one that leaves the underlying duty to comply intact, while dismantling the specific penalty schedule that had been bolted onto it.
To understand what has actually shifted, it helps to revisit what the Maintenance of Standards of Medical Education Regulations, 2023, were meant to do. They were not about curriculum design or teaching methods; they were about accountability. Medical education in India is vast, and the pressure on colleges to claim more faculty, better infrastructure, and larger patient flows than they actually possess has always been intense. The 2023 regulations gave the NMC and its boards a structured way to respond when institutions fell short. They created a graded, escalating system of sanctions, beginning with warnings and directions to fix deficiencies, then moving to financial penalties and restrictions on a college’s day-to-day operations. They also laid out an appeal mechanism, complete with timelines, so that colleges could challenge a penalty they believed was unfair. In theory, this made enforcement predictable: a college knew the consequences of a particular violation, and regulators had a clear script to follow. In practice, it also created a framework that could be applied uniformly across the country, reducing the scope for arbitrary or inconsistent decisions. With the withdrawal of these regulations, that specific penalty structure and its appeal timelines no longer exist as a single governing document. What remains is a patchwork of older and broader legal authorities. That does not mean the NMC is powerless—it simply means the regulator must now look to other instruments, and perhaps craft new ones, if it wants to impose consequences. For institutions, the immediate change is less about escaping accountability and more about losing the certainty of knowing exactly what a given violation will cost.
The financial teeth of the withdrawn regulations were substantial, and their removal will be felt most directly by colleges that had been bracing for enforcement. Under the 2023 rules, a college found guilty of violating prescribed standards could be fined up to one crore rupees for every violation. That is not a token penalty; for a mid-sized medical college, it could mean the difference between solvency and crisis. The regulations also allowed the NMC to withhold or withdraw accreditation for up to five years, a move that would effectively shut down a college’s ability to admit new students and would throw the futures of existing students into doubt. Seats could be reduced, admissions stopped, and applications for new courses frozen. If an institution tried to influence the regulator through intermediaries, its pending applications could be placed on hold indefinitely. These were powerful tools, and they sent a clear signal that medical education was not a business where shortcuts would be tolerated. The withdrawal of the regulations strips out these specific, pre-announced sanctions. But it does not erase the underlying legal landscape. The NMC Act remains in force, and other regulations and statutory provisions continue to govern medical institutions. The practical effect is that enforcement actions may now be less formulaic, more dependent on interpretation, and perhaps more open to legal challenge. That can be read as either a loosening of oversight or an opportunity for a more nuanced, case-by-case approach—depending on where one sits. What is certain is that the era of a fixed, publicly visible penalty schedule has ended, at least for now.
One of the most talked-about provisions in the withdrawn regulations was the personal accountability clause aimed at individuals. Under the 2023 framework, faculty members, heads of departments, deans, directors, and doctors could be fined up to five lakh rupees for submitting false declarations or records, including falsified patient records. The clause was widely seen as a response to the long-running problem of “ghost faculty”—colleges listing doctors and teachers who existed only on paper—and the manipulation of patient data to meet accreditation requirements. By placing individual financial liability on the people who signed off on such documents, the regulations sought to make it personally costly to lie. For whistleblowers and regulators, this was a powerful deterrent. For administrators, it was a source of anxiety, because the paperwork required to run a medical college is enormous, and even an unintentional error could, in theory, expose someone to a steep fine. Now that the specific five-lakh-rupee penalty has been withdrawn, that particular fear has been lifted. But it would be unwise for anyone to conclude that false declarations no longer carry consequences. Fabricating documents, submitting bogus patient records, and misrepresenting faculty strength remain serious violations under other laws. Criminal law does not disappear because a regulation is revoked. If the conduct amounts to cheating, forgery, or conspiracy, prosecutions can still follow. Professional misconduct proceedings, too, may still be initiated under the appropriate regulatory provisions. The removal of one penalty clause does not create immunity; it simply removes one specific, clearly numbered punishment from the books.
The one requirement that has not gone away is the Annual Disclosure Report. Medical colleges must continue to submit their ADRs, detailing their faculty strength, infrastructure, and facilities. This is a critical point, because it anchors the entire regulatory relationship. The ADR is how the NMC knows what a college actually has on the ground—how many qualified teachers are present, how many hospital beds are available, whether the labs are functional, and whether the institution lives up to the promises it made when seeking approval. Even though the 2023 regulations have been withdrawn, the obligation to provide this information persists. The reason is simple: the ADR requirement draws support from the National Medical Commission Act, 2019, which remains fully in force. The withdrawal of the 2023 regulations does not repeal or weaken the Act; it merely strips away one layer of implementing rules. This means that a college that fails to file its ADR, or files one that is false, can still be in serious trouble. The NMC can still ask for data, still inspect institutions, and still take action under the broader framework of the law. For colleges, the practical advice is unchanged: keep your records honest, keep your disclosures accurate, and do not assume that a quieter enforcement environment means no one is watching. The regulator may have lost a favorite rulebook, but it has not lost its authority to ask questions and demand answers. If anything, the absence of fixed penalties may make the process less predictable, which is itself a reason for institutions to stay on the right side of the rules.
So where does this leave the regulation of medical education in India? The immediate, tangible effect of the withdrawal is the disappearance of a defined set of fines, restrictions, and procedural deadlines that governed enforcement under the 2023 regulations. That is a real change, but it is not a vacuum. The NMC Act still stands. Criminal statutes still apply. Professional misconduct provisions remain available. Other regulations—those that define eligibility, curriculum, faculty qualifications, and infrastructure norms—continue to operate. The NMC has broadened, not eliminated, the legal landscape. For institutions that were operating in good faith, the withdrawal may bring a measure of relief from the threat of mechanical, high-value penalties. For those that were cutting corners, it is not a green light to continue. The challenge now is that the absence of a single, clear penalty framework could create uncertainty. When institutions know exactly what a violation will cost, they can plan around it; when consequences are left to be decided case by case, the risk is less calculable, and the burden on regulators to act fairly and consistently becomes greater. The NMC’s broader mandate—to ensure that medical education in India is neither a sham nor a luxury—remains unchanged. The withdrawal of the 2023 regulations is best understood not as an end to accountability, but as a recalibration. The fixed penalties are gone, but the standard they were meant to protect is not. For students, patients, and the public, the hope must be that this change leads to a system that is no less vigilant, only more flexible—and that the next chapter of regulation builds on what was learned, rather than abandoning the goal of quality medical education altogether.